AMPFX
Price
$44.41
Change
-$0.13 (-0.29%)
Updated
Aug 7 closing price
Net Assets
93.92B
RGEBX
Price
$80.11
Change
-$0.15 (-0.19%)
Updated
Aug 7 closing price
Net Assets
324.74B
Interact to see
Advertisement

AMPFX vs RGEBX

Header iconAMPFX vs RGEBX Comparison
Open Charts AMPFX vs RGEBXBanner chart's image
American Funds AMCAP F1
Price$44.41
Change-$0.13 (-0.29%)
VolumeN/A
Net Assets93.92B
American Funds Growth Fund of Amer R2E
Price$80.11
Change-$0.15 (-0.19%)
VolumeN/A
Net Assets324.74B
AMPFX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AMPFX vs. RGEBX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPFX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 325B vs. AMPFX (93.9B). AMPFX pays higher dividends than RGEBX: AMPFX (0.29) vs RGEBX (0.00). AMPFX was incepted earlier than RGEBX: AMPFX (24 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than AMPFX (0.70). AMPFX is a more actively managed with annual turnover of: 36.00 vs. RGEBX (25.00). AMPFX (250) and RGEBX (250) have matching initial minimum investment requirements. RGEBX annual gain was more profitable for investors over the last year : 20.79 vs. AMPFX (12.38). RGEBX return over 5 years is better than : 38.92 vs. AMPFX (26.76).
AMPFXRGEBXAMPFX / RGEBX
Total Expense Ratio0.701.0964%
Annual Report Gross Expense Ratio0.701.0964%
Fund Existence24 years11 years-
Gain YTD5.31212.13644%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets93.9B325B29%
Annual Yield % from dividends0.290.00-
Returns for 1 year12.3820.7960%
Returns for 3 years36.0743.0384%
Returns for 5 years26.7638.9269%
Returns for 10 years57.7676.0376%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITOS10.120.01
+0.15%
iTeos Therapeutics
EXEL37.39-0.32
-0.85%
Exelixis
AIM2.72-0.06
-2.16%
AIM ImmunoTech Inc
VTSI6.97-0.23
-3.19%
VirTra
TWST25.00-0.90
-3.47%
Twist Bioscience Corp